In today’s recent session, 0.72 million shares of the Mainz Biomed N.V. (NASDAQ:MYNZ) have been traded, and its beta is 0.13. Most recently the company’s share price was $0.39, and it changed around $0.03 or 8.72% from the last close, which brings the market valuation of the company to $8.54M. MYNZ at last check was trading at a discount to its 52-week high of $4.38, offering almost -1023.08% off that amount. The share price’s 52-week low was $0.31, which indicates that the recent value has risen by an impressive 20.51% since then. We note from Mainz Biomed N.V.’s average daily trading volume that its 10-day average is 1.21 million shares, with the 3-month average coming to 1.04 million.
Mainz Biomed N.V. (NASDAQ:MYNZ) trade information
Instantly MYNZ has been showing a green trend so far today with a performance of 8.72% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4100 on recent trading dayincreased the stock’s daily price by 4.88%. The company’s shares are currently down -66.35% year-to-date, but still up 0.72% over the last five days. On the other hand, Mainz Biomed N.V. (NASDAQ:MYNZ) is 16.23% up in the 30-day period. We can see from the shorts that 0.37 million shares have been sold at a short interest cover period of 0.22 day(s).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mainz Biomed N.V. (MYNZ) estimates and forecasts
Mainz Biomed N.V. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -59.14 percent over the past six months and at a 45.68% annual growth rate that is well above the industry average of 18.30%. The year-over-year growth rate is expected to be 34.10%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 220k in revenue for the current quarter. 2 analysts expect Mainz Biomed N.V. to make 300k in revenue for the current ending quarter. Analysts predict that the company’s current quarter sales will drop, forecast at -12.00%.
MYNZ Dividends
Mainz Biomed N.V.’s next quarterly earnings report is expected to be released on 2024-Jul-15.
Mainz Biomed N.V. (NASDAQ:MYNZ)’s Major holders
VONTOBEL HOLDING LTD., with 0.1181% or 25000.0 shares worth $10025.0 as of 2024-06-30, holds the second largest percentage of outstanding shares.
The former held 15.19 shares worth $5923.0, making up 0.09% of all outstanding shares.
